Suchergebnisse - "Ai, Weiyun Z"

PubPharm (63)

1

Loncastuximab tesirine in relapsed/refractory diffuse large B-cell lymphoma : long-term efficacy and safety from the phase II LOTIS-2 study

enthalten in: Haematologica | 2024

von Caimi, P. | Ai, W. | Alderuccio, J. | +13

2

PET/CT Biomarkers Enable Risk Stratification of Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma Enrolled in the LOTIS-2 Clinical Trial

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2024

von Alderuccio, J. | Reis, I. | Hamadani, M. | +18

3

Safety and efficacy of tenalisib in combination with romidepsin in patients with relapsed/refractory T-cell lymphoma : results from a phase I/II open-label multicenter study

enthalten in: Haematologica | 2024

von Iyer, S. | Huen, A. | Ai, W. | +13

4

Hypoxia-specific imaging in patients with lymphoma undergoing CAR-T therapy

enthalten in: European journal of nuclear medicine and molecular imaging | 2023

von Banerjee, R. | Wang, V. | Huang, C. | +11

5

Copy Number Loss at Chromosome 14q11.2 Correlates With the Proportion of T Cells in Biopsies and Helps Identify T-Cell Neoplasms

enthalten in: Archives of pathology & laboratory medicine | 2023

von Saglam, A. | Singh, K. | Kumar, J. | +14

6

Hypoxia-specific imaging in patients with lymphoma undergoing CAR-T therapy

enthalten in: European journal of nuclear medicine and molecular imaging | 2023

von Banerjee, R. | Wang, V. | Huang, C. | +11

7

Prognostic Relevance of Dominant Blood T-Cell Clones in Early Mycosis Fungoides-Reply

enthalten in: JAMA dermatology | 2023

von Charli-Joseph, Y. | Pincus, L. | Ai, W.

CommentOn: JAMA Dermatol. 2022 Aug 1;158(8):954-956. - PMID 35731525

8

Loncastuximab tesirine in relapsed/refractory high-grade B-cell lymphoma : a subgroup analysis from the LOTIS-2 study

enthalten in: Blood advances | 2022

von Alderuccio, J. | Ai, W. | Radford, J. | +14

9

Association of a Dominant T-Cell Clone in Peripheral Blood With Time to Systemic Treatment in Patients With Stage IB Mycosis Fungoides

enthalten in: JAMA dermatology | 2022

von Raychaudhuri, S. | Charli-Joseph, Y. | Huang, C. | +3

CommentIn: JAMA Dermatol. 2023 Jan 1;159(1):116. - PMID 36416838

10

Targeting CD70 in cutaneous T-cell lymphoma using an antibody-drug conjugate in patient-derived xenograft models

enthalten in: Blood advances | 2022

von Wu, C. | Wang, L. | Yang, C. | +7

1
2
3
4
5
6
7
Nächster »
[7]